BTSG BrightSpring Health Services, Inc. Common Stock

QT79

NASDAQ·Healthcare·Medical - Healthcare Information Services·USA

Latest market price

66.26

-0.63-0.94%

Overview Short InterestFilings

BTSGQT79BrightSpring Health Services, Inc. Common Stock·NASDAQ

Overview Short InterestFilings

66.26-0.94%

News

Down 0.9% — BrightSpring Health Services, Inc. (BTSG) Q3 2026 Earnings Call Transcript (seekingalpha.com).

Medium confidence

Loading chart...

Signal & projected range

Earnings big beat — drift (PEAD)Historical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

TEM+8.67%$78.48 HNGE+1.01%$115.48 HQY+1.17%$103.67 DOCS+0.34%$32.87 WAY+0.50%$28.14 HTFL-7.72%$54.49 PRVA-0.93%$21.28 OMCL-0.65%$36.41

Snapshot

Index	—	P/E	43.31	EPS (ttm)	1.53	Insider Own	—	Shs Outstand	197.86M	Perf Week	12.53%

Market Cap	13.11B	Forward P/E	27.95	EPS next Y	2.37	Insider Trans	-13.95%	Shs Float	150.65M	Perf Month	9.98%

Enterprise Value	14.72B	PEG	1.40	EPS next Q	0.54			Short Float	7.62%	Perf Quarter	5.56%

Income	338.00M	P/S	0.86	EPS this Y	76.02%			Short Ratio	4.41	Perf Half Y	23.76%

Sales	15.25B	P/B	6.00	EPS next Y	28.24%	ROA	5.40%	Short Interest	11.47M	Perf YTD	76.93%

Book/sh	11.05	P/C	18.26	EPS next 5Y	31.04%	ROE	16.75%	52W High	73.75 -10.16%	Perf Year	102.07%

Cash/sh	3.63	P/FCF	26.65	EPS past 3/5Y	— 48.62%	ROIC	9.83%	52W Low	30.64 116.25%	Perf 3Y	—

Dividend Est.	—	EV/EBITDA	20.73	Sales past 3/5Y	18.69% 18.27%	Gross Margin	12.50%	Volatility	4.83% 3.42%	Perf 5Y	—

Dividend TTM	—	EV/Sales	0.97	EPS Y/Y TTM	150.82%	Oper. Margin	3.61%	ATR (14)	2.57	Perf 10Y	—

Dividend Ex-Date	—	Quick Ratio	1.22	Sales Y/Y TTM	22.86%	Profit Margin	2.22%	RSI (14)	64.88	Recom	2.00

Dividend Gr. 3/5Y	—	Current Ratio	1.62	EPS Q/Q	80.00%	SMA20	6.50%	Beta	1.11	Target Price	79.67

Payout	0.00%	Debt/Eq	1.06	Sales Q/Q	26.36%	SMA50	10.28%	Rel Volume	1.92	Prev Close	66.89

Employees	23,500	LT Debt/Eq	1.05	Earnings	Feb 26	SMA200	20.87%	Avg Volume	2.44M	Price	66.26

IPO Date	Jan 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.22% 8.71%	Net Debt/EBITDA	2.27	Volume	4,687,555	Change	-0.94%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Nov-02-26	Reiterated	UBS	Buy	$85 → $92
Nov-02-26	Reiterated	Goldman Sachs	Buy	$71 → $90
Aug-03-26	Reiterated	Deutsche Bank		$60 → $70
Jul-14-26	Reiterated	Morgan Stanley	Overweight	$71 → $80
Jul-14-26	Reiterated	Keybanc	Overweight	$60 → $80
Jul-13-26	Initiated	Guggenheim	Buy	$81
Jul-13-26	Reiterated	Wells Fargo	Overweight	$61 → $78
Jul-09-26	Initiated	Raymond James	Outperform	$80
Jul-08-26	Reiterated	UBS	Buy	$42 → $85
Jun-22-26	Reiterated	BTIG	Buy	$65 → $90

Latest News· Times ET

Nov-02-26

Nov-02-2602:11PM

BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raisedzacks.com

11:01AM

BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growthzacks.com

Oct-30-26

Oct-30-2602:59PM

BrightSpring Health Services, Inc. (BTSG) Q3 2026 Earnings Call Transcriptseekingalpha.com

11:14AM

BrightSpring Health Services Q3 Earnings Call Highlightsmarketbeat.com

10:31AM

Here's What Key Metrics Tell Us About BrightSpring Health Services, Inc. (BTSG) Q3 Earningszacks.com

08:21AM

BrightSpring Health Services, Inc. (BTSG) Q3 Earnings and Revenues Surpass Estimateszacks.com

06:00AM

BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidanceglobenewswire.com

Oct-29-26

Oct-29-2612:46PM

BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?zacks.com

01:02AM

What to expect from BrightSpring Health Services’s (BTSG) Q3 earningsYahoo

Oct-23-26

Oct-23-2603:49AM

Cantor Fitzgerald Investment Advisors L.P. Makes New $1.74 Million Investment in BrightSpring Health Services, Inc. $BTSGdefenseworld.net

Oct-20-26

Oct-20-2603:53AM

38,367 BrightSpring Health Services, Inc. $BTSG Shares Sold by State of Alaska Department of Revenuedefenseworld.net

Oct-16-26

Oct-16-2606:59AM

2 of Wall Street’s Favorite Stocks to Keep an Eye On and 1 Facing ChallengesYahoo

Oct-14-26

Oct-14-2611:46AM

BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?zacks.com

07:39AM

BrightSpring: Margins Keep Improving While Expanding Its Pharmacy Footprintseekingalpha.com

Oct-13-26

Oct-13-2607:40AM

BrightSpring Health Services: Earnings Are Climbing, But Is The Stock Getting Ahead Of Itself?SeekingAlpha

Company

BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	15,251	12,911	11,266	8,826	—	—	—	—	—
Cost of Goods Sold Incl. D&A	13,344	11,393	9,678	7,392	—	—	—	—	—
Gross Profit	1,907	1,518	1,588	1,434	—	—	—	—	—
Selling, General and Administrative Excl. Other	1,355	1,223	1,382	1,287	—	—	—	—	—
Research and Development	0	0	0	0	—	—	—	—	—
Other Operating Expense	0	0	0	0	—	—	—	—	—
Operating Income	551	295	206	147	—	—	—	—	—
Interest Expense	146	157	228	325	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-30	0	-13	0	—	—	—	—	—
Net Income Before Taxes	376	138	-35	-177	—	—	—	—	—
Income Taxes	65	33	-14	-21	—	—	—	—	—
Consolidated Net Income	338	191	-18	-155	—	—	—	—	—
Net Income From Continuing Operations	312	105	-21	-157	—	—	—	—	—
Net Income	338	191	-18	-155	—	—	—	—	—
EPS (Recurring)	1.64	0.94	-0.09	-0.90	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	1.64	0.94	-0.09	-0.90	—	—	—	—	—
EPS (Diluted)	1.53	0.87	-0.09	-0.90	—	—	—	—	—
EBITDA	710	460	398	350	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	43.31	43.05	—	—	—	—	—	—	—
Price To Sales Ratio	0.90	0.59	0.29	—	—	—	—	—	—
Gross Margin	12.50	11.76	14.10	16.25	—	—	—	—	—
Operating Margin	3.61	2.28	1.83	1.67	—	—	—	—	—
Net Margin	2.22	1.48	-0.16	-1.76	—	—	—	—	—
Shares Outstanding	207	203	193	171	—	—	—	—	—
Market Capitalization	13,716	7,602	3,287	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Greenwell Scott A.	President, PharMerica	Sep 14 '26	Option Exercise	22.27	11,973	266,639	46,345	Sep 16
Greenwell Scott A.	President, PharMerica	Sep 14 '26	Sale	57.91	15,099	874,383	31,246	Sep 16
KKR Phoenix Aggregator L.P.	10% Owner	Jun 05 '26	Sale	58.45	14,669,771	857,492,124	27,154,488	Jun 05
ROUSSEAU JON B	Director, Officer	Jun 05 '26	Option Exercise	6.37	260,000	1,656,200	1,324,503	Jun 05
ROUSSEAU JON B	Director, Officer	Jun 05 '26	Sale	58.75	260,000	15,275,000	0	Jun 05
Nalley Lisa A	Officer	Jun 05 '26	Option Exercise	6.37	35,000	222,950	166,948	Jun 05
Nalley Lisa A	Officer	Jun 05 '26	Sale	58.75	35,000	2,056,250	131,948	Jun 05
Phipps Jennifer A	Chief Financial Officer	Jun 05 '26	Option Exercise	6.37	35,000	222,950	285,224	Jun 05
Phipps Jennifer A	Chief Financial Officer	Jun 05 '26	Sale	58.75	35,000	2,056,250	250,224	Jun 05
KKR Group Partnership L.P.	10% Owner	Jun 05 '26	Sale	58.45	14,669,771	857,492,124	27,154,488	Jun 05
Nalley Lisa A	Officer	Mar 04 '26	Option Exercise	6.37	30,000	191,100	140,594	Mar 06
Nalley Lisa A	Officer	Mar 04 '26	Sale	41.15	30,000	1,234,500	110,594	Mar 06
ROUSSEAU JON B	Director, Officer	Mar 04 '26	Option Exercise	6.37	220,000	1,401,400	1,243,880	Mar 06
ROUSSEAU JON B	Director, Officer	Mar 04 '26	Sale	41.15	220,000	9,053,000	1,023,880	Mar 06
Phipps Jennifer A	Chief Financial Officer	Mar 04 '26	Option Exercise	6.37	35,000	222,950	231,840	Mar 06

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.